Lifecore Biomedical Inc (LFCR)

R&D Expense Growth

2.97%

Fiscal year · Period ending:

LFCR logo

LFCR R&D Expense Growth

Latest reported2.97%
LFCR FY R&D Growth (YoY) (0.00% → 2.97%)
High-resolution chart · PNG

LFCR r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lifecore Biomedical Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
2.9668%
-3.6968%
-1.8429%
11.4428%
17.2801%
-11.8438%
-33.8741%
-10.4219%
35.1209%
31.0598%
3.4345%
-2.9983%
-22.4876%
-3.439%
3.7736%
112.6806%
18.9905%
12.7345%
5.758%
1.0519%
19.6225%
-31.8596%
0%
0%
12.0489%
-30.3663%
-19.0345%
1.7544%
-25%
100%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.